TargED Biopharmaceuticals
Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases.
TargED Biopharmaceuticals has raised €39M across 1 funding round from 8 investors, most recently a Series A round in Feb 2022. Based in Utrecht, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€39M
€39,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2022-02
latest 2022-02
Funding by year
EUR raised per yearTargED Biopharmaceuticals — funding by year — interactive chart.
Data table
| TargED Biopharmaceuticals — funding by year | |
|---|---|
| 2022 | €39M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-24 | Series A | €39M | Andera Partners,Curie Capital,FIRST Fund,FundPlus,Hadean Ventures,INKEF Capital+2 more | View deal → |
Investors
8Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData